14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      LncRNA‐SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR‐338‐3p

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The incidence and death rate of colorectal cancer ( CRC) is very high, which brings great need to understand the early molecular events of CRC. These studies demonstrate that long noncoding RNA (lnc RNA) plays an important role in the occurrence and development of human cancer. Small nucleolar RNA host gene 15 ( SNHG15) was recently identified as a cancer‐related lnc RNA. In this study, we aimed to evaluate the function and mechanism of SNHG15 in CRC. The expression of SNHG15 was detected by quantitative RTPCR ( qRTPCR) in CRC tissues and matched noncancerous tissues ( NCTs). CCK‐8 assay, colony formation assay, flow cytometric analysis, and nude mouse xenograft mode were used to examine the tumor‐promoting function of SNHG15 in vitro and in vivo. The binding relationship between SNHG15, miR‐338‐3p and the target genes of miR‐338‐3p were screened and identified by databases, qRTPCR, dual luciferase reporter assay and western blot. Our results showed that SNHG15 was up‐regulated in CRC tissues compared with paired NCTs ( P < 0.0001). High level of SNHG15 expression predicted poor prognosis of CRC ( P = 0.0051). SNHG15 overexpression could promote cell proliferation and inhibit cell apoptosis. Animal experiments showed that up‐regulation of SNHG15 promoted tumor growth in vivo. The results of mechanism experiments showed that SNHG15 could bind to miR‐338‐3p and block its inhibition on the expression and activity of FOS or RAB14. In conclusion SNHG15 promotes cell proliferation through SNHG15/miR‐338‐3p/ FOSRAB14 axis in CRC.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          The Genetic Signatures of Noncoding RNAs

          The majority of the genome in animals and plants is transcribed in a developmentally regulated manner to produce large numbers of non–protein-coding RNAs (ncRNAs), whose incidence increases with developmental complexity. There is growing evidence that these transcripts are functional, particularly in the regulation of epigenetic processes, leading to the suggestion that they compose a hitherto hidden layer of genomic programming in humans and other complex organisms. However, to date, very few have been identified in genetic screens. Here I show that this is explicable by an historic emphasis, both phenotypically and technically, on mutations in protein-coding sequences, and by presumptions about the nature of regulatory mutations. Most variations in regulatory sequences produce relatively subtle phenotypic changes, in contrast to mutations in protein-coding sequences that frequently cause catastrophic component failure. Until recently, most mapping projects have focused on protein-coding sequences, and the limited number of identified regulatory mutations have been interpreted as affecting conventional cis-acting promoter and enhancer elements, although these regions are often themselves transcribed. Moreover, ncRNA-directed regulatory circuits underpin most, if not all, complex genetic phenomena in eukaryotes, including RNA interference-related processes such as transcriptional and post-transcriptional gene silencing, position effect variegation, hybrid dysgenesis, chromosome dosage compensation, parental imprinting and allelic exclusion, paramutation, and possibly transvection and transinduction. The next frontier is the identification and functional characterization of the myriad sequence variations that influence quantitative traits, disease susceptibility, and other complex characteristics, which are being shown by genome-wide association studies to lie mostly in noncoding, presumably regulatory, regions. There is every possibility that many of these variations will alter the interactions between regulatory RNAs and their targets, a prospect that should be borne in mind in future functional analyses.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Long noncoding RNAs: novel players in colorectal cancer.

            Colorectal cancer (CRC) is the most common type of cancer in the world. Despite its commonness, the underlying mechanism of CRC is not completely understood. Long noncoding RNAs (lncRNAs) have received increased attention with the development of whole genome and transcriptome sequencing technologies. Recent findings reveal that lncRNAs are implicated in serial steps of cancer development. These lncRNAs interact with DNA, RNA, protein molecules and/or their combinations, acting as an essential regulator in chromatin organization, and transcriptional and post-transcriptional regulation. In this review, we highlight recent findings of emerging roles for lncRNAs in CRC and discuss rapid translational lncRNA research for clinical application in diagnosis, prognosis and potential treatment.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Novel classes of non-coding RNAs and cancer

              For the many years, the central dogma of molecular biology has been that RNA functions mainly as an informational intermediate between a DNA sequence and its encoded protein. But one of the great surprises of modern biology was the discovery that protein-coding genes represent less than 2% of the total genome sequence, and subsequently the fact that at least 90% of the human genome is actively transcribed. Thus, the human transcriptome was found to be more complex than a collection of protein-coding genes and their splice variants. Although initially argued to be spurious transcriptional noise or accumulated evolutionary debris arising from the early assembly of genes and/or the insertion of mobile genetic elements, recent evidence suggests that the non-coding RNAs (ncRNAs) may play major biological roles in cellular development, physiology and pathologies. NcRNAs could be grouped into two major classes based on the transcript size; small ncRNAs and long ncRNAs. Each of these classes can be further divided, whereas novel subclasses are still being discovered and characterized. Although, in the last years, small ncRNAs called microRNAs were studied most frequently with more than ten thousand hits at PubMed database, recently, evidence has begun to accumulate describing the molecular mechanisms by which a wide range of novel RNA species function, providing insight into their functional roles in cellular biology and in human disease. In this review, we summarize newly discovered classes of ncRNAs, and highlight their functioning in cancer biology and potential usage as biomarkers or therapeutic targets.
                Bookmark

                Author and article information

                Contributors
                hzhwxsy@126.com , zhaohuihuang@jiangnan.edu.cn
                Journal
                Cancer Med
                Cancer Med
                10.1002/(ISSN)2045-7634
                CAM4
                Cancer Medicine
                John Wiley and Sons Inc. (Hoboken )
                2045-7634
                03 April 2019
                May 2019
                : 8
                : 5 ( doiID: 10.1002/cam4.2019.8.issue-5 )
                : 2404-2413
                Affiliations
                [ 1 ] Wuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi Jiangsu China
                [ 2 ] Cancer Epigenetics Program Wuxi School of Medicine Jiangnan University Wuxi Jiangsu China
                [ 3 ] Pharmacy Department Wuxi 9th People's Hospital Affiliated to Soochow University Wuxi Jiangsu China
                [ 4 ] Department of Surgical Oncology Affiliated Hospital of Jiangnan University Wuxi Jiangsu China
                Author notes
                [*] [* ] Correspondence

                Zhaohui Huang, Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, China.

                Emails: hzhwxsy@ 123456126.com ; zhaohuihuang@ 123456jiangnan.edu.cn

                Author information
                https://orcid.org/0000-0002-0117-9976
                Article
                CAM42105
                10.1002/cam4.2105
                6536931
                30945457
                d55d3bb6-fb38-4248-8f75-b9650a56d7d9
                © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 06 November 2018
                : 29 January 2019
                : 06 March 2019
                Page count
                Figures: 6, Tables: 0, Pages: 10, Words: 5124
                Funding
                Funded by: Hospital Management Centre of Wuxi
                Award ID: YGZXZ1401
                Funded by: Medical Innovation Team Program of Wuxi
                Award ID: CXTP003
                Funded by: Fundamental Research Funds for the Central Universities
                Award ID: JUSRP51710A
                Award ID: NOJUSRP51619B
                Funded by: National Natural Science Foundation of China
                Award ID: 81672328
                Award ID: 81802469
                Award ID: 81772636
                Award ID: 81802462
                Funded by: Medical Key Professionals Program of Jiangsu Province
                Award ID: AF052141
                Funded by: National First‐class Discipline Program of Food Science and Technology
                Award ID: JUFSTR20180101
                Funded by: Natural Science Foundation of Jiangsu Province
                Award ID: BK20150004
                Award ID: BK20151108
                Award ID: BK20180618
                Funded by: Project of the Wuxi Health and Family Planning Commission
                Award ID: Z201806
                Categories
                Original Research
                Cancer Biology
                Original Research
                Custom metadata
                2.0
                cam42105
                May 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.3 mode:remove_FC converted:28.05.2019

                Oncology & Radiotherapy
                colorectal cancer,fos,long noncoding rna,mir‐338‐3p,rab14,small nucleolar rna host gene 15

                Comments

                Comment on this article